Yang X, Yan H, Guo R, Chen Y
Sci Rep. 2025; 15(1):8462.
PMID: 40069258
PMC: 11897350.
DOI: 10.1038/s41598-025-90818-2.
Lee H, Kim J, Go M, Lee H, Kim J, Kim I
J Microbiol Biotechnol. 2025; 35:e2409025.
PMID: 39947694
PMC: 11876019.
DOI: 10.4014/jmb.2409.09025.
Yang W, Yan X, Chen R, Xin X, Ge S, Zhao Y
Cell Death Dis. 2025; 16(1):58.
PMID: 39890803
PMC: 11785999.
DOI: 10.1038/s41419-025-07376-8.
Alpizar Salazar M, Olguin Reyes S, Medina Estevez A, Saturno Lobos J, De Aldecoa Castillo J, Carrera Aguas J
Medicina (Kaunas). 2025; 61(1).
PMID: 39859069
PMC: 11766802.
DOI: 10.3390/medicina61010088.
Alharbi H, Alshebremi M, Babiker A, Rahmani A
Biomolecules. 2025; 15(1).
PMID: 39858545
PMC: 11763763.
DOI: 10.3390/biom15010151.
Lauric-α-linolenic lipids modulate gut microbiota, preventing obesity, insulin resistance and inflammation in high-fat diet mice.
Huang Y, Liu W, Luo X, Zhao M, Wang J, Ullah S
NPJ Sci Food. 2024; 8(1):115.
PMID: 39738097
PMC: 11685730.
DOI: 10.1038/s41538-024-00349-9.
Recent Developments in Drug Design of Oral Synthetic Free Fatty Acid Receptor 1 Agonists.
Liu L, Zhang Q, Ma Y, Lin L, Liu W, Ding A
Drug Des Devel Ther. 2024; 18:5961-5983.
PMID: 39679134
PMC: 11646431.
DOI: 10.2147/DDDT.S487469.
Non-Targeted Metabolomics Reveal Apomorphine's Therapeutic Effects and Lysophospholipid Alterations in Steatohepatitis.
Ogiso H, Miura K, Nagai R, Osaka H, Aizawa K
Antioxidants (Basel). 2024; 13(11).
PMID: 39594434
PMC: 11591194.
DOI: 10.3390/antiox13111293.
Free Cholesterol-Induced Liver Injury in Non-Alcoholic Fatty Liver Disease: Mechanisms and a Therapeutic Intervention Using Dihydrotanshinone I.
Shou J, Ma J, Wang X, Li X, Chen S, Kang B
Adv Sci (Weinh). 2024; 12(2):e2406191.
PMID: 39558866
PMC: 11727260.
DOI: 10.1002/advs.202406191.
Pathogenesis and research progress of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Shan G, Wan H, Zhang Y, Cheng J, Qiao D, Liu Y
World J Hepatol. 2024; 16(10):1142-1150.
PMID: 39474575
PMC: 11514618.
DOI: 10.4254/wjh.v16.i10.1142.
Oxidative Stress and Annexin A2 Differential Expression in Free Fatty Acids-Induced Non-Alcoholic Fatty Liver Disease in HepG2 Cells.
Arruda V, Azevedo G, Granato M, Matos A, Araujo T, Guerra J
Int J Mol Sci. 2024; 25(17).
PMID: 39273539
PMC: 11395542.
DOI: 10.3390/ijms25179591.
Differential association of abdominal, liver, and epicardial adiposity with anthropometry, diabetes, and cardiac remodeling in Asians.
Lee V, Han Y, Toh D, Bryant J, Boubertakh R, Le T
Front Endocrinol (Lausanne). 2024; 15:1439691.
PMID: 39257902
PMC: 11385302.
DOI: 10.3389/fendo.2024.1439691.
9-HODE and 9-HOTrE alter mitochondrial metabolism, increase triglycerides, and perturb fatty acid uptake and synthesis associated gene expression in HepG2 cells.
Evans W, Eccles-Miller J, Anderson E, Farrell H, Baldwin W
Prostaglandins Leukot Essent Fatty Acids. 2024; 202:102635.
PMID: 39142221
PMC: 11404490.
DOI: 10.1016/j.plefa.2024.102635.
Blume Alleviates Non-Alcoholic Fatty Liver Disease Promoted by N-(carboxymethyl)lysine.
Lee J, Gu M, Lee Y, Kim Y, Choi I, Kim D
Nutrients. 2024; 16(14).
PMID: 39064772
PMC: 11280000.
DOI: 10.3390/nu16142330.
Discovery of Cell-Permeable Allosteric Inhibitors of Liver Pyruvate Kinase: Design and Synthesis of Sulfone-Based Urolithins.
Iqbal S, Islam M, Ashraf S, Kim W, Al-Sharabi A, Ozcan M
Int J Mol Sci. 2024; 25(14).
PMID: 39063228
PMC: 11277446.
DOI: 10.3390/ijms25147986.
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease.
Peleman C, Hellemans S, Veeckmans G, Arras W, Zheng H, Koeken I
Cell Death Differ. 2024; 31(9):1113-1126.
PMID: 39060422
PMC: 11369286.
DOI: 10.1038/s41418-024-01348-9.
Alantolactone attenuates high-fat diet-induced inflammation and oxidative stress in non-alcoholic fatty liver disease.
Wang J, Jiang Y, Jin L, Qian C, Zuo W, Lin J
Nutr Diabetes. 2024; 14(1):41.
PMID: 38858382
PMC: 11164993.
DOI: 10.1038/s41387-024-00300-7.
Beneficial Effects of Capybara Oil Supplementation on Steatosis and Liver Apoptosis in Obese Mice.
Lontro Alves L, Gomes Pereira P, Ciambarella B, Porto Campos M, Rabelo K, Nascimento A
J Obes. 2024; 2024:7204607.
PMID: 38831961
PMC: 11147678.
DOI: 10.1155/2024/7204607.
Adipocentric origin of the common cardiometabolic complications of obesity in the young up to the very old: pathophysiology and new therapeutic opportunities.
Sarzani R, Landolfo M, Di Pentima C, Ortensi B, Falcioni P, Sabbatini L
Front Med (Lausanne). 2024; 11:1365183.
PMID: 38654832
PMC: 11037084.
DOI: 10.3389/fmed.2024.1365183.
MYC: there is more to it than cancer.
Zacarias-Fluck M, Soucek L, Whitfield J
Front Cell Dev Biol. 2024; 12:1342872.
PMID: 38510176
PMC: 10952043.
DOI: 10.3389/fcell.2024.1342872.